Cite
MLA Citation
Alberto Martini et al.. “Progression-free survival is an adequate endpoint for clinical trials of locally advanced and metastatic urothelial carcinoma.” Current opinion in urology, vol. 32, no. 5, 2022, pp. 500–503. http://access.bl.uk/ark:/81055/vdc_100160142069.0x000023